Deutsche Bank analyst Justin Bowers maintains $IQVIA Holdings (IQV.US)$ with a buy rating, and adjusts the target price from $270 to $265.
According to TipRanks data, the analyst has a success rate of 42.9% and a total average return of -0.3% over the past year.
Furthermore, according to the comprehensive report, the opinions of $IQVIA Holdings (IQV.US)$'s main analysts recently are as follows:
Iqvia's market is considered relatively stable, although the company is experiencing issues with bookings due to delays and drug failures rather than significant effects from pipeline rationalization.
The company has encountered a challenging industry operating environment. Commentary from the company indicates that pharma portfolio reprioritizations related to the IRA may be concluding, and it seems the company is likely to benefit from the pharmaceutical industry's consolidation of vendors.
Iqvia's recent financial performance surpassed consensus expectations in terms of total revenue, adjusted EBITDA, and adjusted EPS. However, the company has revised its 2024 outlook downward for all metrics. This revision is attributed to the impact of the Inflation Reduction Act and broader economic challenges. Additionally, the guidance for R&DS was lowered following the delay of two major trials and a cancellation.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
